Spots Global Cancer Trial Database for tumor response
Every month we try and update this database with for tumor response cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After Radiochemotherapy | NCT00855946 | Rectal Adenocar... | 18 Years - 80 Years | University Hospital, Bordeaux | ||
| International Registry on Cholangiocarcinoma Treatment | NCT01920503 | Cholangiocarcin... | Doxorubicin | 18 Years - 75 Years | International Group of Endovascular Oncology | |
| Two-week Course Versus Conventionally Fractionated Chemoradiotherapy in Rectal Cancer | NCT02484040 | Response to Tox... Toxicity Recurrence | Two-week course... Two-week course... | 20 Years - 80 Years | Seoul St. Mary's Hospital | |
| A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer | NCT02507544 | Carcinoma Advanced Cancer | TRX-818 capsule... | 18 Years - | TaiRx, Inc. | |
| Bintrafusp Alfa Program Rollover Study | NCT05061823 | Lung Cancer Cancer | Bintrafusp alfa | 18 Years - | EMD Serono | |
| A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer | NCT02507544 | Carcinoma Advanced Cancer | TRX-818 capsule... | 18 Years - | TaiRx, Inc. | |
| Temsirolimus in Combination With Metformin in Patients With Advanced Cancers | NCT01529593 | Advanced Cancer... | Temsirolimus Metformin | 14 Years - | M.D. Anderson Cancer Center | |
| A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor | NCT01396148 | Gastrointestina... | sunitinib malat... sunitinib malat... | 6 Years - 20 Years | Pfizer | |
| Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy | NCT01045044 | Breast Cancer | 18 Years - 65 Years | Kettering Health Network | ||
| Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy | NCT01045044 | Breast Cancer | 18 Years - 65 Years | Kettering Health Network | ||
| Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION | NCT01383746 | Cholestasis, Pr... | Yttrium microsp... | 18 Years - | Assistance Publique - HΓ΄pitaux de Paris | |
| Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After Radiochemotherapy | NCT00855946 | Rectal Adenocar... | 18 Years - 80 Years | University Hospital, Bordeaux | ||
| A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy | NCT00283465 | Anemia Neoplasm | Epoetin alfa | 18 Years - | Janssen-Cilag B.V. | |
| PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer | NCT03611712 | Cancer-related ... Survival Tumor, Esophage... | Astragalus Poly... | 20 Years - 75 Years | PhytoHealth Corporation | |
| Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy | NCT01045044 | Breast Cancer | 18 Years - 65 Years | Kettering Health Network | ||
| Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade | NCT00551798 | Hodgkin's Disea... Malignant Lymph... Chemoresistance | TEP au MIBI | 18 Years - | University Hospital, Limoges | |
| Two-week Course Versus Conventionally Fractionated Chemoradiotherapy in Rectal Cancer | NCT02484040 | Response to Tox... Toxicity Recurrence | Two-week course... Two-week course... | 20 Years - 80 Years | Seoul St. Mary's Hospital | |
| ISP-TACE Versus TACE for HCC With PVTT | NCT03108248 | HCC Portal Vein Tum... | ethiodized oil;... stent; idoine-1... | 20 Years - 75 Years | Zhongda Hospital | |
| Two-week Course Versus Conventionally Fractionated Chemoradiotherapy in Rectal Cancer | NCT02484040 | Response to Tox... Toxicity Recurrence | Two-week course... Two-week course... | 20 Years - 80 Years | Seoul St. Mary's Hospital | |
| Bintrafusp Alfa Program Rollover Study | NCT05061823 | Lung Cancer Cancer | Bintrafusp alfa | 18 Years - | EMD Serono | |
| Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After Radiochemotherapy | NCT00855946 | Rectal Adenocar... | 18 Years - 80 Years | University Hospital, Bordeaux | ||
| Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI) and Fluorothymidine Positron Emission Tomography (FLT PET) in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy | NCT01240681 | Locally Advance... | FLT PET and BOL... | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients | NCT02703298 | Carcinoma Advanced Cancer | TRX-818 capsule... | 20 Years - | TaiRx, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
